Company News: Page (1) of 1 - 02/04/14 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

Cerner Reports Fourth Quarter and Full Year 2013 Results

(February 04, 2014)

KANSAS CITY, Mo., Feb. 4, 2014 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq:CERN) today announced results for the 2013 fourth quarter and full year that ended December 28, 2013, delivering strong levels of bookings and revenue performance.



Bookings in the fourth quarter of 2013 were $1.11 billion, an all-time high and an increase of 9 percent compared to fourth quarter 2012 bookings of $1.02 billion, which was the previous all-time high. Full-year 2013 bookings were a record $3.77 billion, up 20 percent compared to 2012 bookings of $3.14 billion.



Fourth quarter revenue was $795.3 million, an increase of 12 percent compared to $710.4 million in the year-ago period. Full year 2013 revenue was $2.91 billion, up 9 percent compared to 2012 revenue of $2.67 billion.


On a U.S. Generally Accepted Accounting Principles (GAAP) basis, fourth quarter 2013 net earnings were $60.1 million and diluted earnings per share were $0.17. Fourth quarter 2012 GAAP net earnings were $111.8 million and diluted earnings per share were $0.32. For the full year, 2013 GAAP net earnings were $398.4 million and diluted earnings per share were $1.13. Full year 2012 GAAP net earnings were $397.2 million and diluted earnings per share were $1.13.




The number of shares and the per share amounts for all periods presented within reflect the two-for-one stock split effective June 28, 2013.



Adjusted (non-GAAP) Net Earnings



Adjusted net earnings for fourth quarter 2013 were $136.7 million, an increase of 16 percent compared to $118.2 million of adjusted net earnings in the fourth quarter of 2012. Adjusted diluted earnings per share were $0.39 in the fourth quarter of 2013 compared to $0.34 of adjusted diluted earnings per share in the year-ago quarter. Analysts' consensus estimate for fourth quarter 2013 adjusted diluted earnings per share was $0.39. For the full year 2013, adjusted net earnings were $496.8 million and adjusted diluted earnings per share were $1.41, compared to full year 2012 adjusted net earnings of $420.8 million and adjusted diluted earnings per share of $1.20.



Adjusted net earnings is not a recognized term under GAAP and should not be substituted for net earnings as a measure of Cerner's performance but instead should be utilized as a supplemental measure of financial performance in evaluating our business. Following is a description of adjustments made to net earnings. For more detail, please see the accompanying schedule, titled "Reconciliation of GAAP Results to Non-GAAP Results."



Fourth quarter 2013 adjusted net earnings and diluted earnings per share exclude share-based compensation expense and a settlement charge. These items reduced fourth quarter 2013 net earnings and diluted earnings per share by $76.6 million and $0.22, respectively. Fourth quarter 2012 adjusted net earnings and diluted earnings per share exclude share-based compensation expense, which reduced net earnings and diluted earnings per share by $6.4 million and $0.02, respectively. Share based compensation expense and the settlement charge reduced full-year 2013 net earnings and diluted earnings per share by $98.4 million and $0.28, respectively. Share based compensation expense reduced full year 2012 net earnings and diluted earnings per share by $23.5 million and $0.07, respectively.



Other 2013 Fourth Quarter and Full-Year Highlights:




  • Fourth quarter cash collections of $781.8 million and operating cash flow of $141.5 million. For the full year, cash collections were $3.05 billion and operating cash flow was $695.9 million.


  • Fourth quarter free cash flow of negative $41.7 million, reflecting the impact of the settlement charge. For the full year, free cash flow was $168.3 million, compared to $424.7 million in 2012, with the decline due to an increase in capital expenditures and capitalized software related to facilities needs and growth initiatives and the fourth quarter settlement charge. Free cash flow is a non-GAAP financial measure defined as GAAP cash flows from operating activities less capital purchases and capitalized software development costs. For more detail, please see the accompanying schedule, titled "Reconciliation of GAAP Results to Non-GAAP Results."


  • Fourth quarter days sales outstanding of 67 days, which is down from 74 days in the year-ago quarter.


  • Total backlog of $8.91 billion, up 23 percent over the year-ago quarter. This was comprised of $8.13 billion of contract backlog and $786.0 million of support and maintenance backlog.



"Cerner's fourth quarter results reflect a strong finish to the year," Neal Patterson, Cerner chairman, CEO and co-founder said. "In addition to delivering strong operating results in 2013, we invested heavily in our cloud solutions and infrastructure, and I believe these investments are positioning Cerner for growth through the decade. IT is growing in importance as health care undergoes an unprecedented amount of change, and we believe Cerner's solutions and services are well aligned with helping stakeholders improve quality and lower costs while adapting to the evolving landscape."



Future Period Guidance



Cerner currently expects:




  • First quarter 2014 revenue between $770 million and $810 million.


  • Full year 2014 revenue between $3.2 billion and $3.4 billion.


  • First quarter 2014 adjusted diluted earnings per share before share based compensation expense between $0.36 and $0.37.


  • Full year 2014 adjusted diluted earnings per share before share based compensation expense between $1.62 and $1.67.


  • First quarter 2014 new business bookings between $860 million and $930 million.


  • Share based compensation expense to reduce diluted earnings per share by approximately $0.03 in the first quarter of 2014 and between $0.11 and $0.12 for the year.



Earnings Conference Call



Cerner will host an earnings conference call to provide additional detail on these results at 3:30 p.m. CT on February 4. The dial-in number for the conference call is (857)-244-7551; the passcode is Cerner. Cerner recommends joining the call 15 minutes early for registration. The re-broadcast of the call will be available from 6:30 p.m. CT, February 4 through 11:59 p.m. CT, February 7. The dial-in number for the re-broadcast is (617)-801-6888; the passcode is 61186290.



An audio webcast will be available live and archived on Cerner's website at www.cerner.com under the About Cerner section (click Investor Relations, then Presentations and Webcasts).



About Cerner



Cerner is contributing to the systemic change of health and care delivery. For more than 30 years Cerner has been executing its vision to make health care safer and more efficient. We started with the foundation of digitizing paper processes and now offer the most comprehensive array of information software, professional services, medical device integration, remote hosting and employer health and wellness services. Cerner systems are used by everyone from individual consumers, to single-doctor practices, hospitals, employers and entire countries. Taking what we've learned over more than three decades, Cerner is building on the knowledge that is in the system to support evidence-based clinical decisions, prevent medical errors and empower patients in their care.



Cerner® solutions are licensed by approximately 14,000 facilities around the world, including more than 3,000 hospitals; 4,900 physician practices; 60,000 physicians; 590 ambulatory facilities, such as laboratories, ambulatory centers, behavioral health centers, cardiac facilities, radiology clinics and surgery centers; 3,500 extended care facilities; 150 employer sites and 1,790 retail pharmacies.



Certain trademarks, service marks and logos (collectively, the "Marks") set forth herein are owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. All other non-Cerner Marks are the property of their respective owners. Nasdaq: CERN. For more information about Cerner, please visit www.cerner.com, Twitter, Facebook and YouTube.



This release contains forward-looking statements that involve a number of risks and uncertainties. It is important to note that Cerner's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words "believe", "positioning", "guidance", "expect" or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the possibility of product-related liabilities; potential claims for system errors and warranties; the possibility of interruption at our data centers or client support facilities; our proprietary technology may be subject to claims for infringement or misappropriation of intellectual property rights of others, or may be infringed or misappropriated by others; risks associated with our non-U.S. operations; risks associated with our ability to effectively hedge exposure to fluctuations in foreign currency exchange rates; the potential for tax legislation initiatives that could adversely affect our tax position and/or challenges to our tax positions in the United States and non-U.S. countries; risks associated with our recruitment and retention of key personnel; risks related to our dependence on third party suppliers; risks inherent with business acquisitions; the potential for losses resulting from asset impairment charges; risks associated with uncertainty in global economic conditions; managing growth in the new markets in which we offer solutions, health care devices and services; changing political, economic, regulatory and judicial influences; government regulation; significant competition and market changes; variations in our quarterly operating results; potential inconsistencies in our sales forecasts compared to actual sales; volatility in the trading price of our common stock and the timing and volume of market activity; our directors' authority to issue preferred stock and the anti-takeover provisions in our corporate governance documents; and material adverse resolution of legal proceedings. Additional discussion of these and other risks, uncertainties and factors affecting Cerner's business is contained in Cerner's periodic filings with the Securities and Exchange Commission. The reader should not place undue reliance on forward-looking statements, since the statements speak only as of the date that they are made. Cerner undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time.



















































































































































































































































































































































































 

CERNER CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

 

 

 

 

For the three and twelve months ended December 28, 2013 and December 29, 2012

 

 

 

 

(unaudited)

 

 

 

 

 

 

 

 

 

(In thousands, except per share data)

Three Months Ended

Years Ended

 

2013 (1)

2012 (1)

2013 (1)

2012 (1)

Revenues

 

 

 

 

System sales

 $ 245,772

 $ 251,759

 $ 847,809

 $ 902,799

Support, maintenance and services

 531,107

 445,098

 1,992,830

 1,707,329

Reimbursed travel

 18,449

 13,527

 70,109

 55,308

Total revenues

 795,328

 710,384

 2,910,748

 2,665,436

 

 

 

 

 

Margin

 

 

 

 

System sales

 160,978

 142,496

 545,435

 475,343

Support, maintenance and services

 492,234

 414,777

 1,850,591

 1,581,896

Total margin

 653,212

 557,273

 2,396,026

 2,057,239

 

 

 

 

 

Operating expenses

 

 

 

 

Sales and client service

 319,838

 274,550

 1,173,051

 1,020,640

Software development

 92,443

 78,624

 338,786

 301,370

General and administrative

 157,182

 43,655

 308,177

 163,567

Total operating expenses

 569,463

 396,829

 1,820,014

 1,485,577

 

 

 

 

 

Operating earnings

 83,749

 160,444

 576,012

 571,662

 

 

 

 

 

Other income, net

 2,756

 7,257

 12,042

 16,046

 

 

 

 

 

Earnings before income taxes

 86,505

 167,701

 588,054

 587,708

Income taxes

 (26,442)

 (55,893)

 (189,700)

 (190,476)

Net earnings

 $ 60,063

 $ 111,808

 $ 398,354

 $ 397,232

 

 

 

 

 

Basic earnings per share

 $ 0.17

 $ 0.33

 $ 1.16

 $ 1.16

 

 

 

 

 

Basic weighted average shares outstanding

 343,501

 343,487

 343,636

 341,861

 

 

 

 

 

Diluted earnings per share

 $ 0.17

 $ 0.32

 $ 1.13

 $ 1.13

 

 

 

 

 

Diluted weighted average shares outstanding

 352,131

 352,361

 352,281

 351,394

 

 

 

 

 

Note 1: Operating expenses for the three and twelve months ended December 28, 2013 and December 29, 2012 include share-based compensation expense. The impact of this expense on net earnings and diluted earnings per share is presented below:

 

 

 

 

 

(In thousands, except per share data)

Three Months Ended

Years Ended

 

2013

2012

 2013 

 2012 

 

 

 

 

 

Sales and client service

 $ 6,973

 $ 5,100

 $ 24,058

 $ 17,316

Software development

 2,949

 2,322

 11,096

 9,217

General and administrative

 3,415

 2,922

 13,800

 11,579

Total share-based compensation

 13,337

 10,344

 48,954

 38,112

Amount of related income tax benefit

 (4,788)

 (3,957)

 (18,607)

 (14,578)

Net impact on net earnings

 $ 8,549

 $ 6,387

 $ 30,347

 $ 23,534

 

 

 

 

 

Decrease to diluted earnings per share

 $ 0.03

 $ 0.02

 $ 0.09

 $ 0.07








 





































































































































































































 

CERNER CORPORATION AND SUBSIDIARIES

RECONCILIATION OF GAAP RESULTS TO NON-GAAP RESULTS1

For the three and twelve months ended December 28, 2013 and December 29, 2012

(unaudited)

 

RECONCILIATION OF ADJUSTED NET EARNINGS TO GAAP NET EARNINGS1

 

(In thousands)

Three Months Ended

Years Ended

 

2013

2012

 2013 

 2012 

Net Earnings

 

 

 

 

Net earnings (GAAP)

 $ 60,063

 $ 111,808

 $ 398,354

 $ 397,232

Share-based compensation expense, net of tax

 8,549

 6,387

 30,347

 23,534

Settlement charge, net of tax2

 68,078

 —

 68,078

 —

Adjusted net earnings (non-GAAP)3

 $ 136,690

 $ 118,195

 $ 496,779

 $ 420,766

 

 

 

 

 

RECONCILIATION OF ADJUSTED DILUTED EARNINGS PER SHARE TO GAAP DILUTED EARNINGS PER SHARE1

 

 

 

 

 

 

Three Months Ended

Years Ended

 

2013

2012

 2013 

 2012 

Diluted Earnings Per Share

 

 

 

 

Diluted earnings per share (GAAP)

 $ 0.17

 $ 0.32

 $ 1.13

 $ 1.13

Share-based compensation expense, net of tax

 0.03

 0.02

 0.09

 0.07

Settlement charge, net of tax2

 0.19

 —

 0.19

 —

Adjusted diluted earnings per share (non-GAAP)3

 $ 0.39

 $ 0.34

 $ 1.41

 $ 1.20

 

 

 

 

 

RECONCILIATION OF NON-GAAP FREE CASH FLOW TO GAAP OPERATING CASH FLOW1

 

 

 

 

 

(In thousands)

Three Months Ended

Years Ended

 

2013

2012

 2013 

 2012 

Cash flows from operating activities (GAAP)

 $ 141,480

 $ 180,554

 $ 695,865

 $ 708,314

Capital purchases

 (134,471)

 (53,463)

 (352,877)

 (183,429)

Capitalized software development costs

 (48,698)

 (27,683)

 (174,649)

 (100,189)

Free cash flow (non-GAAP)4

 $ (41,689)

 $ 99,408

 $ 168,339

 $ 424,696


Note 1: The presentation of Adjusted Diluted Earnings per Share, Adjusted Net Earnings and Free Cash Flow, non-GAAP financial measures, are not meant to be considered in isolation, nor as a substitute for, or superior to, Generally Accepted Accounting Principles (GAAP) results and investors should be aware that non-GAAP measures have inherent limitations and should be read only in conjunction with Cerner's consolidated financial statements prepared in accordance with GAAP. Adjusted Diluted Earnings per Share, Adjusted Net Earnings and Free Cash Flow may also be different from similar non-GAAP financial measures used by other companies and may not be comparable to similarly titled captions of other companies due to potential inconsistencies in the method of calculations. We believe that Adjusted Diluted Earnings per Share, Adjusted Net Earnings and Free Cash Flow are important to enable investors to better understand and evaluate our ongoing operating results and allows for more comprehensive review and understanding of our overall financial, operational and economic performance.



Note 2: The settlement charge is presented net of an income tax benefit of $38.1 million.



Note 3: Cerner provides earnings with and without share-based compensation expense and settlement charge because earnings excluding these expenses is used by management along with GAAP results to analyze its business, make strategic decisions and for management compensation purposes.



Note 4: Cerner provides free cash flow because it takes into account the capital expenditures necessary to operate our business.






































































































































































































































CERNER CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

As of December 28, 2013 (unaudited) and December 29, 2012

 

 

 

(In thousands)

2013

2012

 

 

 

Assets

 

 

Current assets:

 

 

Cash and cash equivalents

 $ 202,377

 $ 317,120

Short-term investments

 677,004

 719,665

Receivables, net

 582,926

 577,848

Inventory

 32,299

 23,681

Prepaid expenses and other

 175,488

 113,572

Deferred income taxes, net

 91,614

 38,620

Total current assets

 1,761,708

 1,790,506

 

 

 

Property and equipment, net

 792,781

 569,708

Software development costs, net

 347,077

 267,307

Goodwill

 307,422

 247,616

Intangible assets, net

 144,132

 132,045

Long-term investments

 554,873

 509,467

Other assets

 190,371

 187,819

Total assets

 $ 4,098,364

 $ 3,704,468

 

 

 

Liabilities and Shareholders' Equity

 

 

Current liabilities:

 

 

Accounts payable

 $ 145,019

 $ 141,212

Current installments of long-term debt and capital lease obligations

 54,107

 59,582

Deferred revenue

 209,746

 189,652

Accrued payroll and tax withholdings

 147,986

 125,253

Other accrued expenses

 83,574

 64,413

Total current liabilities

 640,432

 580,112

 

 

 

Long-term debt and capital lease obligations

 111,717

 136,557

Deferred income taxes and other liabilities

 170,392

 143,212

Deferred revenue

 8,159

 10,937

Total liabilities

 930,700

 870,818

 

 

 

Shareholders' Equity:

 

 

Common stock

 3,443

 3,442

Additional paid-in capital

 812,853

 840,769

Retained earnings

 2,393,048

 1,994,694

Treasury stock

 (28,251)

 —

Accumulated other comprehensive loss, net

 (13,429)

 (5,255)

Total shareholders' equity

 3,167,664

 2,833,650

Total liabilities and shareholders' equity

 $ 4,098,364

 $ 3,704,468

CONTACT: Investor Contact: Allan Kells
(816) 201-2445, akells@cerner.com
Media Contact: Megan Moriarty
(816) 888-2470, megan.moriarty@cerner.com
Cerner's Internet Home Page: www.cerner.com

Page: 1


Related Keywords: HEALTH, INSURANCE, EARNINGSPro AV, Post/Production, Management, Presentors, Management, Internet/Web, Business, Internet, Webcasting, Standards/Initiatives, Business Issues, Internet Media, Presentation, Corporate/Company, Events, webcast, USA, Surgery, medical technologists, Surgery, Physician, Science, Financial, Internet Technology, Medical, Computer Science, Business, Internet, Judicial, Other, Medical Professionals,


DMO TEXT LINKS
(Click here to place a textlink on this site)

Get 10 days of free unlimited access to lynda.com.
What do you want to learn today? Online video tutorials to help you learn software, creative, and business skills.
Click Here!


16 GB USB
iPhone 5c 16 GB White Smartphone - AT&T (1.3 GHz Dual-Core Processor, 1 GB RAM, 16 GB Internal Storage, iOS 7, 4G, 8 MP Camera)
By Apple, start from $ 309.99
With 2 Reviews.
Galaxy Note 4 White Smartphone - AT&T (2.7 GHz Quad-Core Processor, 3GB RAM, 32 GB Internal Storage, Android 4.4, 4G, 16 MP Camera)
By Samsung, start from $ 825.99
Moto X 16 GB Black Smartphone - Verizon Wireless 2014 Model (2.5 GHz Quad-Core Processor, 2 GB RAM, 16 GB Internal Storage, Android 5.0, 4G, 13 MP Camera)
By Motorola, start from $ 149.99
iPhone 6 Plus 16 GB Silver Smartphone - Verizon Wireless (1.4 GHz Dual-Core Processor, 1 GB RAM, 16 GB Internal Storage, iOS 8, 4G, 8 MP Camera)
By Apple, start from $ 299.99
Galaxy Note 4 White Smartphone - Sprint (2.7 GHz Quad-Core Processor, 3GB RAM, 32 GB Internal Storage, Android 4.4, 4G, 16 MP Camera)
By Samsung, start from $ 720.00
Galaxy S5 16GB Black Smartphone - Verizon (2.5 GHz Quad-Core Processor, 2 GB RAM, 16 GB Internal Storage, Android 4.4, 4G, 16 MP Camera)
By Samsung, start from $ 249.99
HOT THREADS on DMN Forums
Content-type: text/html  Rss  Add to Google Reader or
Homepage    Add to My AOL  Add to Excite MIX  Subscribe in
NewsGator Online 
Real-Time - what users are saying - Right Now!
Windows OS
EML to PST Conveter • richardaberry  
    • Re: EML to PST Conveter • Amelie Moore

@ Copyright, 2014 Digital Media Online, All Rights Reserved